COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Group 1 - CollPlant Biotechnologies will report its financial results for Q3 2024 on November 27, 2024, before U.S. market opening [1] - A conference call and webcast will be held on the same day at 10:00 a.m. EST to discuss the financial results and corporate updates [1] - The company specializes in regenerative and aesthetic medicine, focusing on non-animal-derived collagen for tissue regeneration and medical aesthetics [1][5] Group 2 - CollPlant's products are based on rhCollagen, produced through proprietary plant-based genetic engineering technology, addressing tissue repair, aesthetics, and organ manufacturing [5] - In 2021, CollPlant entered a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, a leader in the dermal filler market [6]